Abstract:Background: Non-small cell lung cancer (NSCLC) is the most common histological type of lung cancer, and one of the malignant tumor with the highest mortality. As the main part of the optical molecular imaging probe, peptide can realize the early screening and diagnosis of tumor and improve the survival rate of patients. The aim of this study was to screen the small-molecule peptide that highly binds to NSCLC NCI-H1299 cells using in vivo phage display technology and to identify their binding specificity by in vitro experiment. Methods: To prepare a tumor-bearing nude mouse model of NCI-H1299 cells, after 3 rounds of in vivo screening with Ph.D.-C7CTM Peptide Library, phage clones were randomly picked, using immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) to identify the affinity of phage clones to NCI-H1299 cells. The positive monoclonal phages DNA was extracted and sequenced to obtain the amino acid sequence of the peptides. The peptides with the highest repetition rate was chemically synthesized and labeled with fluorescein (FITC) to prepare optical molecular probe. We preliminary identified the specificity of the probe binding to lung cancer cells by in vitro experiment. Results: After three rounds of in vivo screening, the phages enrichment rate was 341.3 times compared with the first round. Immunohistochemical staining showed that with the increase of screening times, the phages binding to tumor tissues continued to increase, and the binding amount was significantly higher than normal tissues; ELISA results showed that 20 clones among the 30 randomly selected phage clones were positive. After sequencing, the peptide with the highest repetition rate was synthesized and named NSP1; Methyl thiazolyl tetrazolium assay (MTT) and would healing assay showed that NSP1 will not affect cell proliferation and migration. Flow cytometry and immunofluorescence showed specific binding of NSP1 to NCI-H1299 cells. Conclusions: We successfully obtained the peptide NSP1 that specifically binds to lung cancer NCI-H1299 cells by in vivo phage display, which provide a theoretical basis for NSCLC early diagnosis and targeted therapy.

Identification and characterization of a novel phage display-derived peptide with affinity for human brain metastatic breast cancer.

Enhanced Antitumor Effects of the BRBP1 Compound Peptide BRBP1-TAT-KLA on Human Brain Metastatic Breast Cancer.

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

Targeted NIRF/MR Dual-Mode Imaging of Breast Cancer Brain Metastasis Using BRBP1-functionalized Ultra-Small Iron Oxide Nanoparticles

SPECT and Near-Infrared Fluorescence Imaging of Breast Cancer with a Neuropilin-1-Targeting Peptide

Identifying Peptides That Specifically Bind to MDA-MB-468 Breast Cancer Cells*

A blood-brain barrier and blood-brain tumor barrier penetrating peptide derived targeted therapeutics for glioma and malignant tumor brain metastases.

Affinity characterization of GE11 peptide to brain metastases from epidermal growth factor recep?tor?overexpressing human breast cancer

Identification Of Vegfr2-Binding Peptides Using High Throughput Bacterial Display Methods And Functional Assessment

In Vivo Selection of Phage Sequences and Characterization of Peptide-Specific Binding to Breast Cancer Cells

Identification of a Novel Afgf-Binding Peptide with Anti-Tumor Effect on Breast Cancer from Phage Display Library

Phage display peptide probes for imaging early response to bevacizumab treatment

Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library

Identification of a peptide that crosses the blood-cerebrospinal fluid barrier by phage display technology

Identification of a Novel Peptide Ligand of Human Transfrrin Receptor 1 for Targeted Tumor Delivery Drug

[Screening and Identification of the Peptides Specifically Binding to Human Non-small Cell Lung Cancer NCI-H1299 Cells]

Specific Phage-Displayed Peptides Binding to Tumor Vasculature

Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging.

All-stage targeted therapy for the brain metastasis from triple-negative breast cancer

Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display

Identification and Characterization of Tumor Antigens by Using Antibody Phage Display and Intrabody Strategies